(2-Amino-5-chlorophenyl)(2,6-difluorophenyl)methanone, 95.0%, 100g

1-(2-HYDROXYETHYL)PIPERAZIN-2-ONE HCL, 95.0%, 250mg

3,3-Dibromo-1H-pyrrolo[2,3-b]pyridin-2(3H)-one, 95.0%, 250mg

8-METHOXYQUINOLINE-5-CARBOXYLIC ACID, 95.0%, 250mg

9-Anthracenemethanol, 98.0%, 500g

(3S,5S,6S,8R,9S,10R,13S,14S,17S)-10,13-DIMETHYLHEXADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-3,6,17-TRIOL, 98%, 250mg

N,N,N',N'-Tetrakis(2-methoxyethyl)propanediamide, 95%, 100mg

4-Isopropoxyaniline>98.0%(GC)(T)25g

(S)-5-Bromo-2,3-dihydro-1H-inden-1-amine hydrochloride, 95.0%, 1g

1-(Pyridazin-3-yl)ethanone, 95.0%, 10g

4-Trifluoromethylphenylglyoxal hydrate, 95.0%, 25g

GC capillary column ROTI®Cap-FFAP, 30 m, 0.25 mm, 0.25 µm, 1 Piece(s)

[(4R)-2,2-Dimethyl-5-oxo-1,3-dioxolan-4-yl]acetic acid, 97.0%, 5g